CA2953159A1 - Inhibiteurs de matriptase et utilisations associees - Google Patents
Inhibiteurs de matriptase et utilisations associees Download PDFInfo
- Publication number
- CA2953159A1 CA2953159A1 CA2953159A CA2953159A CA2953159A1 CA 2953159 A1 CA2953159 A1 CA 2953159A1 CA 2953159 A CA2953159 A CA 2953159A CA 2953159 A CA2953159 A CA 2953159A CA 2953159 A1 CA2953159 A1 CA 2953159A1
- Authority
- CA
- Canada
- Prior art keywords
- disorders
- compound
- treatment
- prevention
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21109—Matriptase (3.4.21.109)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2953168A CA2953168A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953159A CA2953159A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953166A CA2953166A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA3085853A CA3085853A1 (fr) | 2016-12-23 | 2017-12-21 | Inhibiteurs de la matriptase et leurs utilisations |
PCT/CA2017/051575 WO2018112648A1 (fr) | 2016-12-23 | 2017-12-21 | Inhibiteurs de la matriptase et leurs utilisations |
US16/471,979 US10988505B2 (en) | 2016-12-23 | 2017-12-21 | Matriptase inhibitors and uses thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2953168A CA2953168A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953159A CA2953159A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953166A CA2953166A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2953159A1 true CA2953159A1 (fr) | 2018-06-23 |
Family
ID=62624057
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2953168A Abandoned CA2953168A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953166A Abandoned CA2953166A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953159A Abandoned CA2953159A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA3085853A Pending CA3085853A1 (fr) | 2016-12-23 | 2017-12-21 | Inhibiteurs de la matriptase et leurs utilisations |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2953168A Abandoned CA2953168A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
CA2953166A Abandoned CA2953166A1 (fr) | 2016-12-23 | 2016-12-23 | Inhibiteurs de matriptase et utilisations associees |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3085853A Pending CA3085853A1 (fr) | 2016-12-23 | 2017-12-21 | Inhibiteurs de la matriptase et leurs utilisations |
Country Status (3)
Country | Link |
---|---|
US (1) | US10988505B2 (fr) |
CA (4) | CA2953168A1 (fr) |
WO (1) | WO2018112648A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112996529A (zh) * | 2018-10-02 | 2021-06-18 | 迪斯克医药公司 | Matriptase 2抑制剂及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2836511C (fr) | 2011-06-02 | 2021-10-19 | SOCPRA Sciences Sante et Humaines S.E.C. | Inhibiteurs de matriptase et utilisations de ceux-ci contre les infections a orthomyxoviridae |
-
2016
- 2016-12-23 CA CA2953168A patent/CA2953168A1/fr not_active Abandoned
- 2016-12-23 CA CA2953166A patent/CA2953166A1/fr not_active Abandoned
- 2016-12-23 CA CA2953159A patent/CA2953159A1/fr not_active Abandoned
-
2017
- 2017-12-21 CA CA3085853A patent/CA3085853A1/fr active Pending
- 2017-12-21 WO PCT/CA2017/051575 patent/WO2018112648A1/fr active Application Filing
- 2017-12-21 US US16/471,979 patent/US10988505B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2953166A1 (fr) | 2018-06-23 |
CA3085853A1 (fr) | 2018-06-28 |
US20190337981A1 (en) | 2019-11-07 |
WO2018112648A1 (fr) | 2018-06-28 |
CA2953168A1 (fr) | 2018-06-23 |
US10988505B2 (en) | 2021-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2607045C2 (ru) | Бензиламиновые производные как ингибиторы калликреина плазмы | |
JP5226679B2 (ja) | 酵素阻害のための化合物 | |
JP6034802B2 (ja) | 大環状ラクタムの調製のための方法および中間体 | |
JP2001527058A (ja) | ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物 | |
US10975119B2 (en) | Selective cysteine protease inhibitors and uses thereof | |
JPH06504547A (ja) | ペプチドケトアミド、ケト酸およびケトエステル | |
CA2934964C (fr) | Nouveaux derives cyp-eicosanoide | |
US10988505B2 (en) | Matriptase inhibitors and uses thereof | |
CA3196153A1 (fr) | Derives de pyrido[4,3-b]indole et leur utilisation comme produits pharmaceutiques | |
WO2013070118A1 (fr) | Acides (3k,4k,58)-4-acylamion-5-amino-3-(1-étyl-propoxy)-cyclohex-1-ène-carboniques, leurs éthers et procdé d'application | |
TW201412745A (zh) | N-[2-({2-[(2S)-2-氰基吡咯啶-1-基]-2-側氧乙基}胺基)-2-甲基丙基]-2-甲基吡唑并[1,5-a]嘧啶-6-甲醯胺之結晶 | |
US6172256B1 (en) | Chiral-β-amino acid compounds and derivatives thereof | |
KR20040081182A (ko) | 엘라스타제-저해 활성을 가진 이종고리 화합물 및 그 중간체 | |
JP2001139534A (ja) | バリン誘導体およびその用途 | |
ZA200300080B (en) | Thrombin inhibitors comprising an aminoisoquinoline group. | |
CN111171025B (zh) | 靶向eEF2K降解剂的制备及其抗乳腺癌的应用 | |
CN104529833B (zh) | 取代的环丁烷羧酸类化合物及其用途 | |
JPH0548237B2 (fr) | ||
JP2006070014A (ja) | 2−アミノベンゾチアゾール誘導体 | |
WO2020010021A1 (fr) | Composés et méthodes thérapeutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20190716 |